BroadcomvsHealth Catalyst

AVGO and HCAT stock compared: price, dividend, valuation and results, from SEC filings.

AVGO

Broadcom Inc.

$354.05

Value $1.68T

+2.46%
AVGO's page

HCAT

Health Catalyst, Inc

$1.29

Value $95M

-0.72%
HCAT's page

Broadcom (AVGO) has a market value of $1.68T and Health Catalyst (HCAT) $95M. Over the last year, with dividends, AVGO moved +0.5% and HCAT -39.6%. Dividend yield: AVGO 0.73%, HCAT none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AVGO$1.68T

    HCAT$95M

    AVGO is 17,684 times HCAT

  • Revenue, 12 months

    AVGO$89.1B

    HCAT$272M

    AVGO is 327 times HCAT

  • Net income, 12 months

    AVGO$38.3B

    HCAT-$202M

  • Operating margin

    AVGO48.1%

    HCAT-65.7%

    113.8 points apart

  • ROIC

    AVGO27.3%

    HCAT-44.9%

    72.1 points apart

  • P/E

    AVGO43.9

    HCAT–

  • Dividend yield

    AVGO0.7%

    HCAT0.0%

    0.7 points apart

  • 5-year return

    AVGO+556.1%

    HCAT-97.3%

    653.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AVGO+556.1%

HCAT-97.3%

025050075020222023202420252026
Returns by period
PeriodAVGOWith dividendsHCATWith dividends
1 year since November 14, 2025+0.5%Price -0.3%-39.6%Price -39.6%
3 years since November 17, 2023+260.8%+53.4% a yearPrice +249.4%-82.4%-44.0% a yearPrice -82.4%
5 years since November 16, 2021+556.1%+45.7% a yearPrice +500.6%-97.3%-51.4% a yearPrice -97.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AVGOBroadcomHCATHealth Catalyst

Valuation

AVGOHCAT
Valuation
Price$354.05$1.29
Market value$1.68T$95M
Enterprise value (EV)$1.71T$16M
P/E43.9–
P/E, 5-year median30.4–
P/B16.80.7
EV/EBIT40.0–
Free cash flow yield2.4%27.1%

Results and growth

AVGOHCAT
Results and growth
Revenue, 12 months$89.1B$272M
Net income, 12 months$38.3B-$202M
Free cash flow, 12 months$39.4B$26M
Earnings per share, 12 months$7.84-$2.85
Revenue growth, year on year23.9%1.5%
Revenue growth a year, past+21.7%over 5 years+10.5%over 5 years
EPS growth a year, past+49.8%over 5 years–

Margins and returns on capital

AVGOHCAT
Margins and returns on capital
Gross margin68.8%49.1%
Operating margin48.1%-65.7%
Net margin42.9%-74.2%
ROIC27.3%-44.9%
ROE45.4%-105.0%

Balance sheet

AVGOHCAT
Balance sheet
Cash$24.0B$79M
Total debt$59.4B$16M
Net debt / EBITDA0.8–
Interest cover13.7×–

Dividends and buybacks

AVGOHCAT
Dividends and buybacks
Dividend yield0.7%–
Dividend per share, 12 months$2.60–
Dividend growth a year, past+12.7%over 5 years–
Buyback yield0.2%5.3%
Shareholder yield0.9%5.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AVGO or HCAT

Didn't find what you were looking for?

Ask us
Which is bigger, Broadcom or Health Catalyst?

By market value, Broadcom ($1.68T) is about 17,683.7 times Health Catalyst ($95M), at today's prices.

How did AVGO and HCAT stock do over the last 5 years?

Since November 16, 2021, AVGO's price moved +500.6% and HCAT's -97.3%. With dividends: AVGO +556.1% (+45.7% a year), HCAT -97.3% (-51.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AVGO or HCAT?

The dividend yield at today's price is 0.73% for Broadcom and none for Health Catalyst. Over the last twelve months they paid $2.60 and – per share.

Which has the higher profit margins, Broadcom or Health Catalyst?

Over the last twelve months, the net margin was 42.9% for Broadcom and -74.2% for Health Catalyst, and the operating margin 48.1% and -65.7%. Revenue was $89.1B and $272M.

Which is the better investment, Broadcom or Health Catalyst?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.